Immunomodulation with P40, an insoluble delipidated fraction of Corynebacterium granulosum. I.--Immune response to sheep red blood cells. 1982

M J Fuster, and P H Lagrange

The immunological responses to sheep red blood cells (SRBC) were evaluated in mice in order to study the immunomodulating effects of an insoluble fraction of Corynebacterium granulosum, designated P40. A single intravenous (IV) injection of 50 micrograms or more of P40 was able to stimulate the reticulo-endothelial system, as measured by the spleen index. A single IV injection of 250 micrograms of P40, given seven days prior to IV sensitization of groups of mice with varying doses of SRBC, was able to amplify both humoral and cellular immune responses. Lower doses of P40 given subcutaneously (SC) were able to potentiate delayed-type hypersensitivity (DTH) to SRBC. Potentiation depends on the route, dose and time of the P40 injection in relation to the time and route of sensitization. A bimodal activity of P40 was observed: one peak was noted with SRBC were mixed with P40, and a second peak occurred when P40 was injected at the same site four to five days prior to immunization. Maximal potentiation was achieved when SRBC were introduced SC together with 5 micrograms of P40. DTH reached a higher level in animals immunized under the influence of P40; however, the kinetics of the development and decay of DTH were the same in treated and non-treated mice. Immunopotentiation was demonstrated by passive transfer: using the same number of spleen cells from treated or non-treated immune mice, higher DTH reactions were observed in normal recipients when they received spleen cells from P40-treated donor mice. Immunopotentiation seemed to act by increasing the number of committed lymphocytes and not by augmenting the number of accessory cells, since adoptive transfer of DTH by immune cells was not different in normal or P40-treated recipients.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D003352 Corynebacterium A genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens.
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006388 Hemagglutinins Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Isohemagglutinins,Exohemagglutinins,Hemagglutinin
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

M J Fuster, and P H Lagrange
June 1984, Asian Pacific journal of allergy and immunology,
M J Fuster, and P H Lagrange
September 1971, Infection and immunity,
M J Fuster, and P H Lagrange
January 1989, Developmental and comparative immunology,
M J Fuster, and P H Lagrange
September 1977, Journal of immunology (Baltimore, Md. : 1950),
M J Fuster, and P H Lagrange
January 1991, Journal of experimental animal science,
Copied contents to your clipboard!